搜索
EyePoint Pharmaceuticals Inc
EYPT添加自选
4.250USD
+0.020+0.47%
收盘 09-11 16:00（美东）
361.17M总市值
亏损市盈率 TTM
EyePoint Pharmaceuticals Inc (EYPT) 营收表现
更新时间: 2025年12月31日去年，EyePoint Pharmaceuticals Inc表现最佳的业务板块YUTIQ实现营收1.60M美元。United States的营收贡献最高，去年达到29.98M美元。
业务
营业收入
占比
年报
年报
单季报
YUTIQ
DEXYCU
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
YUTIQ
1.60M(100.00%)
3.10M(100.00%)
14.23M(100.00%)
28.33M(70.99%)
16.96M(48.03%)
13.88M(66.62%)
12.05M(71.60%)
DEXYCU
--(--)
--(--)
--(--)
11.58M(29.01%)
18.35M(51.97%)
6.95M(33.38%)
4.78M(28.40%)
地区
营业收入
占比
年报
年报
单季报
United States
China
United Kingdom
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
United States
29.98M(95.56%)
42.05M(97.17%)
45.27M(98.37%)
40.48M(97.77%)
35.99M(97.43%)
22.62M(65.70%)
19.14M(94.00%)
1.11M(37.84%)
China
1.29M(4.12%)
1.12M(2.60%)
648.00K(1.41%)
823.00K(1.99%)
851.00K(2.30%)
11.71M(34.01%)
1.12M(5.50%)
1.72M(58.74%)
United Kingdom
100.00K(0.32%)
100.00K(0.23%)
100.00K(0.22%)
100.00K(0.24%)
100.00K(0.27%)
100.00K(0.29%)
100.00K(0.49%)
100.00K(3.42%)